Gil Rabinovici, MD
Associate Professor of Neurology
Born and raised in Jerusalem, Dr. Rabinovici received his BS degree from Stanford University and MD from Northwestern University Medical School. He completed an internship in internal medicine at Stanford University, neurology residency (and chief residency) at UCSF and a behavioral neurology fellowship at the Memory and Aging Center (MAC).
Dr. Rabinovici participates in patient evaluations and management. On the research front, he leads the MAC PET imaging program and is principle investigator of a cohort study of early-onset Alzheimer’s disease and of Imaging Dementia: Evidence for Amyloid Scanning (IDEAS), a national study sponsored by the Centers for Medicare and Medicaid Services to assess the clinical utility of amyloid PET launching in 2016. His work investigates how structural, functional and molecular brain imaging techniques can be used to improve diagnostic accuracy in dementia and to study the biology of neurodegenerative diseases, with the goal of accelerating treatment development. Dr. Rabinovici’s work is supported by the National Institutes of Health (NIA and NINDS), the Alzheimer’s Association, the American College of Radiology, the John Douglas French Alzheimer's Foundation, the Tau Consortium, the Association for Frontotemporal Lobar Degeneration and Avid radiopharmaceuticals/Eli Lilly. Awards recognizing his work include the 2015 Christopher Clark Award for Advancement of the Field of Amyloid Imaging, the 2012 American Academy of Neurology Research Award in Geriatric Neurology and the 2010 Best Paper in Alzheimer’s Disease Neuroimaging: New Investigator Award from the Alzheimer’s Association.